The Growing GLP-1 Market Landscape: Key Insights for Pharma Marketers

Download now
People engaged in a discussion while reviewing a presentation on a laptop, sharing ideas and feedback.
The Growing GLP-1 Market Landscape: Key Insights for Pharma Marketers

From skyrocketing prescriptions to unprecedented ad spending, this report explores the GLP-1 landscape for pharma marketers planning for the next big wave in obesity and metabolic disorder treatments.

Inside this guide, you’ll find key insights on:

  • The evolving role of GLP-1 receptor agonists in patient care
  • Challenges such as drug shortages, insurance coverage, and safety concerns
  • FDA updates and risks related to compounded GLP-1 products
  • What’s next for GLP-1 medications: emerging treatments and innovations

Discover the noteworthy trends in this unique market space.

Download now

1 O'Brien, J. (2024). MediaRadar CEO: What the ‘enormous’ increase in GLP-1 ad spend means. MM+M, https://www.mmm-online.com/home/channel/mediaradar-ceo-what-the-enormous-increase-in-glp-1-ad-spend-means/
2 Mahase, E. (2024). GLP-1 agonists: US sees 700% increase over four years in number of patients without diabetes starting treatment. BMJ, q1645. https://doi.org/10.1136/bmj.q1645
3 epocrates analytics